Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SUPN | RDY | TSHA | ||
| Company | Supernus Pharm | Dr. Reddy's Laboratories Ltd ADR | Taysha Gene Therapies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 43.67 | 13.30 | 6.24 | ||
| High | 44.58 | 13.36 | 6.57 | ||
| Low | 43.54 | 13.21 | 6.24 | ||
| Latest | 44.38 | 13.29 | 6.42 | ||
| Change | +0.80 | +0.14 | +0.23 | ||
| % Change | +1.84% | +1.06% | +3.72% | ||
| Volume | 1,096,000 | 2,007,800 | 6,368,900 | ||
| 20-Day Average Volume | 625,940 | 1,531,260 | 2,532,555 | ||
| Previous Close | 43.58 | 13.15 | 6.19 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 45.40 | 13.35 | 5.73 | ||
| 20-Day Raw Stochastic | 26.15% | 37.02% | 88.73% | ||
| 20-Day Relative Strength | 40.78 | 48.41 | 58.76 | ||
| Weighted Alpha | +19.99 | -11.81 | +74.94 | ||
| Today's Opinion | 88% Sell | 96% Sell | 80% Buy | ||
| Previous Opinion | 88% Sell | 88% Sell | 72% Buy | ||
| Last Month's Opinion | 32% Sell | 88% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.57% since 06/11/26 | -0.52% since 06/11/26 | +15.05% since 06/11/26 | ||
| Low | 42.45 on 06/16/26 | 13.08 on 06/17/26 | 5.55 on 06/12/26 | ||
| High | 45.71 on 06/12/26 | 13.43 on 06/15/26 | 6.57 on 06/18/26 | ||
| 1-Month | |||||
| %Chg | -8.17% since 05/18/26 | -2.28% since 05/18/26 | +17.91% since 05/18/26 | ||
| Low | 42.45 on 06/16/26 | 12.95 on 06/03/26 | 5.17 on 05/20/26 | ||
| High | 49.83 on 05/22/26 | 13.86 on 05/26/26 | 6.57 on 06/18/26 | ||
| 3-Month | |||||
| %Chg | -9.96% since 03/18/26 | -4.11% since 03/18/26 | +44.27% since 03/18/26 | ||
| Low | 42.45 on 06/16/26 | 12.19 on 05/12/26 | 4.03 on 03/30/26 | ||
| High | 52.96 on 05/06/26 | 14.31 on 03/19/26 | 7.30 on 05/06/26 | ||
| 6-Month | |||||
| %Chg | -9.94% since 12/18/25 | -4.66% since 12/18/25 | +17.80% since 12/18/25 | ||
| Low | 42.45 on 06/16/26 | 12.19 on 05/12/26 | 4.03 on 03/30/26 | ||
| High | 59.68 on 02/25/26 | 14.80 on 02/25/26 | 7.30 on 05/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,575,815 | 11,092,472 | 1,844,858 | ||
| Shares Outstanding, K | 58,040 | 834,648 | 287,361 | ||
| Annual Sales | 718,950,000 | 3,580,000,000 | 9,770,000 | ||
| Annual Net Income | -38,550,000 | 456,000,000 | -109,000,000 | ||
| Last Quarter Sales | 207,710,000 | 593,010,000 | 5,490,000 | ||
| Last Quarter Net Income | -2,290,000 | -10,780,000 | -27,850,000 | ||
| 60-Month Beta | 0.55 | 0.27 | 1.19 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.59 on 05/05/26 | 0.06 on 05/12/26 | -0.12 on 05/06/26 | ||
| Earnings Date | 08/04/26 | 07/22/26 | 08/11/26 | ||
| Most Recent Dividend | N/A | 0.071 on 07/25/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 07/24/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 17.86 | 21.56 | 0.00 | ||